106 related articles for article (PubMed ID: 4027876)
1. Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis.
Rotstein S; Blomgren H; Petrini B; Wasserman J; Nilsson B; Baral E
Cancer; 1985 Sep; 56(6):1413-9. PubMed ID: 4027876
[TBL] [Abstract][Full Text] [Related]
2. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
3. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
Das SN; Khanna NN; Khanna S
Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
[TBL] [Abstract][Full Text] [Related]
4. Immunological characterization of mononuclear cells in peripheral blood and regional lymph nodes of breast cancer patients.
Heidenreich W; Jagla K; Schüssler J; Börner P; Dehnhard F; Kalden JR; Leibold W; Peter HH; Deicher H
Cancer; 1979 Apr; 43(4):1308-13. PubMed ID: 376089
[TBL] [Abstract][Full Text] [Related]
5. Blood lymphocyte subsets in operable breast-cancer - relation to extent of tumor disease and prognosis.
Blomgren H; Glas U; Gustavssonkadaka E; Nilsson B; Petrini B; Rotstein S; Wasserman J
Int J Oncol; 1993 Apr; 2(4):627-32. PubMed ID: 21573602
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
7. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
8. Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.
Eremin O; Roberts P; Plumb D; Stephens JP
Br J Cancer; 1980 Jan; 41(1):62-72. PubMed ID: 7362780
[TBL] [Abstract][Full Text] [Related]
9. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
Fedin IuV; Ermilova VD
Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
[TBL] [Abstract][Full Text] [Related]
10. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
11. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
12. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
[TBL] [Abstract][Full Text] [Related]
13. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
14. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
15. [Local cellular immune reactions in cancer patients].
Bilynskiĭ BT; Vasil'ev NV; Volod'ko NA
Vopr Onkol; 1988; 34(7):819-26. PubMed ID: 3420824
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of axillary lymph node cells in patients with breast cancer.
Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
Magrath IT; Simon RM
Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
20. Effect of an intramuscular injection of human leukocyte interferon on blood leukocyte counts and proportions of lymphocytes forming E, EA and EAC rosettes.
Einhorn S; Blomgren H; Strander H
Int Arch Allergy Appl Immunol; 1980; 63(2):139-44. PubMed ID: 6158481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
